PharmacoEconomics

Methods of Economic Evaluation for the German Statutory Healthcare System
pp. 1-4(4)
Author: Dong, Hengjin

The Applicability and Generalizability of Findings from Clinical Trials for Health-Policy Decisions
pp. 5-10(6)
Authors: Freemantle, Nick; Hessel, Franz

Is Medication Review by Primary-Care Pharmacists for Older People Cost Effective?: A Narrative Review of the Literature, Focusing on Costs and Benefits
pp. 11-24(14)
Authors: Zermansky, Arnold G.; Silcock, Jonathan

Statin Therapy in Rheumatoid Arthritis: A Cost-Effectiveness and Value-of-Information Analysis
pp. 25-37(13)
Authors: Bansback, Nick; Ara, Roberta; Ward, Sue; Anis, Aslam; Choi, Hyon K.

Treating Relapsing Multiple Sclerosis with Subcutaneous versus Intramuscular Interferon-Beta-1a: Modelling the Clinical and Economic Implications
pp. 39-53(15)
Authors: Guo, Shien; Bozkaya, Duygu; Ward, Alexandra; O'Brien, Judith A.; Ishak, Khajak; Bennett, Randy; Al-Sabbagh, Ahmad; Meletiche, Dennis M.

Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma
pp. 55-68(14)
Authors: Fagnoni, Philippe; Milpied, Noel; Limat, Samuel; Deconinck, Eric; Nerich, Virginie; Foussard, Charles; Colombat, Philippe; Harousseau, Jean-Luc; Woronoff-Lemsi, Marie-Christine

Comparing the Cost Effectiveness of Risperidone and Olanzapine in the Treatment of Schizophrenia Using the Net-Benefit Regression Approach
pp. 69-80(12)
Authors: >Annemieke De Ridder,; >Diana De Graeve,

Estimating the Cost of Diabetes Mellitus-Related Events from Inpatient Admissions in Sweden Using Administrative Hospitalization Data
pp. 81-90(10)
Authors: Gerdtham, Ulf-G; Clarke, Philip; Hayes, Alison; Gudbjornsdottir, Soffia